Who makes [14C]KWA-0711?

[14C]KWA-0711 is developed by Kissei Pharmaceutical Co., Ltd..

Last reviewed 2026-05-15 · How we verify

[14C]KWA-0711

Kissei Pharmaceutical Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	[14C]KWA-0711
Sponsor	Kissei Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]KWA-0711 CI brief — competitive landscape report
[14C]KWA-0711 updates RSS · CI watch RSS
Kissei Pharmaceutical Co., Ltd. portfolio CI